ArticlemedRxiv : the preprint server for health sciences2025
Prior knowledge informs graph neural networks to improve phenotype prediction from proteomics.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
High-throughput proteomics data provides dense individual-level molecular readouts, enabling the development of machine learning models for predicting diverse phenotypes relevant to patient health. Proteins interact in the cell in complex, nonlinear relationships that may not be reflected by linear models or simple machine learning approaches, highlighting the potential for more expressive deep neural networks to improve performance. Despite this possibility, in practice, developing neural network approaches in biological domains has been a significant challenge. We developed a deep learning framework for predicting disease-related traits from protein expression data using an innovative model architecture designed to exploit structured biological knowledge. The core of the model is a graph neural network (GNN) operating on bipartite graphs where one set of nodes represents protein expression levels and the other represents hundreds of protein sets derived from gene ontology libraries. Edges encode set membership, providing a compact and biologically meaningful structure. We trained our model using the UK Biobank plasma proteomics and individual phenotype data. Of the architectures we examined, the best-performing architecture had three parallel heads: two GNNs each using graphs constructed with independent protein set libraries and one global head consisting of tabular protein expression data. Their outputs are concatenated and passed through a dense feed-forward network to predict phenotype. When applied to predicting glycated hemoglobin (HbA1c) levels and a range of other phenotypes, our model showed strong predictive performance, outperforming other deep learning architectures and simpler linear models. Control models with permuted protein labels displayed worse performance demonstrating that the model benefits from the inductive bias from incorporating prior knowledge, especially in settings with limited training data. We present an innovative model architecture incorporating biological domain knowledge to predict complex traits from large scale proteomic data.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.